South Korea allows data exclusivity for pediatric drugs approved through foreign clinic... Min Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies By Min Son July 14 2021
Drug patent expiry in 2021: Opportunities and challenges in the Korean market By Min Son January 12 2021
South Korea strengthens IP protection through legislative measures By Hyun-Sil Lee & Minji Ryan Kim August 20 2020
South Korea: Supreme Court’s en banc ruling drops registration defence for later-regist... By Min Son May 20 2021
